Mod GRF 1-29 & Ipamorelin Blend (10mg) – Premium Research Peptide Synergy

Welcome to Liaocheng Yixin Company, your trusted source for premium mod grf 1-29 ipamorelin blend 10mg for research. As a specialized peptide synthesis manufacturer operating from our facility in Shandong Province, China, we provide high-quality research compounds for the global scientific community.

This blend combines Mod GRF 1-29 (also known as CJC-1295 without DAC), a stabilized analog of growth hormone-releasing hormone, with Ipamorelin, a highly selective ghrelin receptor agonist . Together, they represent what is widely regarded as the “gold standard” GHRH/GHRP stack in peptide research . Our mod grf 1-29 ipamorelin blend 10mg for research offers investigators a reliable, high-purity tool for growth hormone axis studies, body composition research, and tissue regeneration protocols.

What is the Mod GRF 1-29 & Ipamorelin Blend?

This research blend combines two mechanistically complementary peptides that target distinct receptors on pituitary somatotroph cells :

Mod GRF 1-29 (CJC-1295 without DAC)

• Modified 29-amino acid GHRH analog with four amino acid substitutions (positions 2, 8, 15, and 27) 

• Resists DPP-IV cleavage, extending half-life to ~30 minutes (vs. ~7 minutes for native GRF 1-29) 

• Activates GHRH receptors via the Gs/cAMP/PKA pathway

• Drives GH gene transcription and vesicle priming—”fills the gun” 

Ipamorelin

• Selective pentapeptide ghrelin receptor (GHS-R1a) agonist 

• Activates the Gq/PLC/IP3/calcium pathway

• Triggers immediate GH vesicle exocytosis—”pulls the trigger” 

• Distinguished by its clean selectivity profile: no significant elevation of ACTH, cortisol, or prolactin 

Key Identifiers:

• Mod GRF CAS: 863288-34-0 

• Mod GRF MW: ~3,367.9 Da 

• Ipamorelin MW: ~711.85 Da 

• Purity: ≥99% verified by HPLC

Mechanism of Action in Research

Dual-Pathway Synergy

The blend’s research value lies in its synergistic activation of two independent intracellular signaling cascades on the same pituitary cell . Mod GRF 1-29 engages the GHRH receptor, activating adenylyl cyclase and increasing cAMP. This drives GH gene transcription, GH protein synthesis, and priming of secretory vesicles. Simultaneously, Ipamorelin activates GHS-R1a, triggering PLC/IP3/calcium signaling that directly causes exocytosis of pre-formed GH vesicles .

Neither pathway alone achieves what both produce together. The combined GH pulse is 3-5 times greater than either peptide in isolation .

Pulsatile, Not Sustained Release

Both components have short half-lives—Mod GRF 1-29 at approximately 30 minutes and Ipamorelin at approximately 2 hours . This creates a discrete GH pulse that mimics endogenous physiological secretion patterns, preserving natural GH pulsatility rather than producing sustained tonic elevation . This pulsatile pattern is believed to be more effective for activating hepatic GH receptors and stimulating IGF-1 production .

Scientific Research Applications

Growth Hormone Axis Studies

The blend is used to investigate GHRH and ghrelin pathway synergy in pituitary models. Foundational work by Bowers et al. (1990) demonstrated that GHRH and GHRP co-administration produces GH responses significantly exceeding additive predictions .

Adipose Tissue Research

Research hypothesizes that Mod GRF 1-29 and Ipamorelin, through their effects on GH dynamics, may influence lipolysis (fat breakdown), adipogenesis (fat cell formation), and adipose tissue endocrine activity .

Bone Cell Research

Growth hormone plays a recognized role in bone metabolism. Studies suggest these peptides may stimulate osteoblast activity and proliferation, influence osteoclast modulation, and support bone matrix deposition .

Body Composition Studies

The blend is investigated for effects on lean mass and adipose tissue. The pulsatile GH stimulation preferentially activates the growth-promoting STAT5b signaling pathway and avoids GH resistance that occurs with constant receptor stimulation .

Why Choose Liaocheng Yixin Company?

When sourcing mod grf 1-29 ipamorelin blend 10mg for research, quality and reliability are paramount. Here’s why researchers trust us:

Manufacturer-Direct Quality

We are a legitimate, licensed peptide synthesis company with a physical headquarters in Shandong Province, China. Our facility maintains strict quality control standards.

Verified Purity Standards

Every batch undergoes rigorous testing using HPLC analysis. Certificates of Analysis are available upon request.

Research-Grade Specifications

• Purity: ≥99% verified by HPLC

• Appearance: White lyophilized powder

• Storage: Store powder at -20°C in a sealed container, protected from light and moisture

• Form: Lyophilized powder for research use

Quality Assurance & Testing

Every batch undergoes comprehensive quality control:

1. Synthesis by experienced chemists using solid-phase peptide synthesis

2. Purification via preparative HPLC

3. Analysis using HPLC for purity verification

4. Mass Spectrometry for molecular weight confirmation

5. Packaged in sterile conditions for research use

When you need premium mod grf 1-29 ipamorelin blend 10mg for research for your pituitary function, metabolic, or tissue regeneration studies, choose a manufacturer that prioritizes quality, transparency, and reliability. Liaocheng Yixin Company combines expert peptide synthesis capabilities with rigorous quality control to deliver research materials you can trust.